Skip to main content
. 2017 Dec 19;9(3):3805–3814. doi: 10.18632/oncotarget.23454

Table 2. TILs culture in vitro and CD4/CD8 composition of expanded TILs in 8 SCCHN patients.

Patient No No. of missense mutations No. of HLA-A restricted neoantigen candidates (the affinity of <500 nM) No. of cells at the starting point No. of expanded TILs Expanded TILs
CD4 (%) CD8 (%)
B1 51 7 N/A N/A N/A N/A
B2 1779 251 1×105CD8+cells 8.0×107 N/A 93.0
B3 11 0 6×106 single cells 9.0×108 25.7 67.5
B4 48 4 1×105CD8+cells 8.3×107 N/A 95.7
B5 4290 532 6×106 single cells 2.4×108 84.0 11.4
B6 49 19 6×106 single cells 5.1×107 34.5 42.3
B7 78 14 6×106 single cells 2.0×109 39.5 56.5
B8 901 273 6×106 single cells 1.8×109 34.4 58.0

N/A: Not applicable.